| 0.94 -0.013 (-1.38%) | 10-02 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.23 |
1-year : | 1.31 |
| Resists | First : | 1.05 |
Second : | 1.12 |
| Pivot price | 1.02 |
|||
| Supports | First : | 0.93 |
Second : | 0.78 |
| MAs | MA(5) : | 0.97 |
MA(20) : | 1.02 |
| MA(100) : | 1.13  |
MA(250) : | 1.75 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 3.7 |
D(3) : | 6.9 |
| RSI | RSI(14): 34.6 |
|||
| 52-week | High : | 3.9 | Low : | 0.76 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AMST ] has closed below the lower bollinger band by 1.4%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ AMST ] is to continue within current trading range. It is unclear right now based on current values. 69.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 73 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.98 - 0.99 | 0.99 - 0.99 |
| Low: | 0.92 - 0.93 | 0.93 - 0.94 |
| Close: | 0.93 - 0.94 | 0.94 - 0.95 |
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
Wed, 23 Sep 2026
Amesite Inc. Submits 2026 Annual Report Detailing Shares, Market Value, and Operational Risks - Kalkine Media
Wed, 23 Sep 2026
A 2,700-patient deployment contrasts with doubts about Amesite (AMST)'s ability to stay in business. - Stock Titan
Wed, 09 Sep 2026
Amesite Inc. (AMST) Edges Higher: Stock Gains 1.89% to $1.08 Within Established Range - Key Reversal Day - careplusvn.com
Mon, 07 Sep 2026
Price to earnings forward of Amesite Inc. – NASDAQ:AMST - TradingView
Tue, 19 May 2026
AMST Stock Spikes As NurseMagic Deal Confirms Nasdaq Comeback - StocksToTrade
Tue, 19 May 2026
AMST Stock Jumps As NurseMagic Deal Confirms Scalability - timothysykes.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 3.67e+006 (%) |
| Held by Institutions | 32.9 (%) |
| Shares Short | 7 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -3.12e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 329.5 % |
| Return on Equity (ttm) | -64.2 % |
| Qtrly Rev. Growth | 364780 % |
| Gross Profit (p.s.) | 41.9 |
| Sales Per Share | -114.84 |
| EBITDA (p.s.) | 364780 |
| Qtrly Earnings Growth | -0.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 2.29 |
| Dividend | 0 |
| Forward Dividend | 25470 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|